Saturday November 21 2009 | Biotechnology feed | All feeds
|
|
|
News Articles on JohnsonEF Johnson Technologies Announces Third Quarter Results-- a $3.3 million Statewide Hybrid Project 25 Trunked and Conventional First Responder Radio System."Thir Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact LensesORLANDO, Fla., Nov. 11 /PRNewswire-FirstCall/ -- Contact lenses prescribed for longer replacement intervals can lead to more extreme over w Nine Leading Research Teams Selected to Study How Digital Games Improve Players' HealthResearchers seek to discover how interactive video games can be designed to improve physical activity, prevention behaviors and self-ma NEW BRUNSWICK, N.J., Nov. 5 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 18th Annual Healt IRVING, Texas, Nov. 4 /PRNewswire-FirstCall/ -- EF Johnson Technologies, Inc. (Nasdaq: EFJI) announced today that the Company w Awards Going to Researchers in CA, DC, MI, NY, and PA; Studies Explore How Games Can Improve or Prevent Chronic Conditions, Increas NEW BRUNSWICK, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced g EVANSVILLE, Ind., Oct. 19 /PRNewswire-FirstCall/ -- In the first year of life, nutrition is critical to establishing a foundation f EVANSVILLE, Ind., Oct. 16 /PRNewswire/ -- Early nutrition is critical to establishing a foundation for lifelong growth, health and well-bei NEW BRUNSWICK, N.J., Oct. 6 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time EVANSVILLE, Ind., Oct. 2 /PRNewswire/ -- Early nutrition is critical to establishing a foundation for lifelong growth, health and w NEW BRUNSWICK, N.J., and LEIDEN, Netherlands, Sept. 28 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) and Crucell, N.V MORRIS PLAINS, N.J., Sept. 17 /PRNewswire/ -- The makers of LISTERINE(R) and REACH(R) TOTAL CARE introduce an exclusive, limited-edition bo LOS ANGELES, July 10 /PRNewswire-USNewswire/ -- Today, Earvin "Magic" Johnson, Chairman and Founder of the Magic Johnson Foundation (MJF) In the news release, Johnson & Johnson Completes Acquisition of Cougar Biotechnology, issued earlier today by Johnson & Johnson over PR New NEW BRUNSWICK, N.J., July 10 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced it has successfu NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced that the initial LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Bi While both boys and girls experience value-added benefits beyond vision correction, girls experience stronger boost in self esteem with switch Dental Hygienists Acknowledged for Educational Activities Beyond the Call of Duty MORRIS PLAINS, N.J., June 19 /P NEW BRUNSWICK, N.J., June 17 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced the U.S. Federal Trade Commission has gran More than 300 Join to Discuss Health Game Trends and Developments at Boston Hyatt Harborside June 11-12 NEW BRUNSWICK, N.J., June 5 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ), through a new wholly-owned subsidiary, Kite Merger Sub, In Early stage compounds and new filings targeted in five therapeutic areas Expanding indications for strong core produ Innovative Public/Private Partnership Launches at State Legislative Hearing TRENTON, N.J., May 28 /PRNewswire-USNewswire/ Free "Eye Health & Allergies" brochure available from Asthma & Allergy Foundation of America JACKSONVIL NEW BRUNSWICK, N.J., May 27 /PRNewswire-FirstCall/ -- In an arbitration demand filed today with the American Arbitration Association, Johnson & NEW BRUNSWICK, N.J., May 27 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceutical business for the i Data Confirm Tapentadol Efficacy and Tolerability for Acute Pain Patients RARITAN, N.J., May 26 /PRNewswire-USNewswire/ -- NEW BRUNSWICK, N.J., May 13 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Deutsche Bank 34th Annual Health Ca Offers more affordable, convenient way to buy annual supply of ACUVUE(R) Brand Contact Lenses JACKSONVILL NEW BRUNSWICK, N.J., May 12 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for financial JACKSONVILLE, Fla., May 12 /PRNewswire/ -- What we see determines what we do; and for children in particular, good eye health and optimal vision ar NEW BRUNSWICK, N.J., May 7 /PRNewswire-FirstCall/ -- In letters to Senate Special Committee on Aging Chairman Herb Kohl (D-WI) and Senate Finance C Safety and Efficacy Data from Phase 3 Study will be Highlighted SAN DIEGO, May 7 /PRNewswire-USNewswire/ -- Chronic pain is First new multifocal contact lens from ACUVUE(R) in 11 years combines unique Stereo Precision Technology(TM) optics and innov IRVING, Texas, May 6 /PRNewswire-FirstCall/ -- EF Johnson Technologies, Inc. (Nasdaq: EFJI) today announced its results for the quarter ended March NEW BRUNSWICK, N.J., May 5 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Bank of America and Merrill Lynch 20 SKILLMAN, N.J., April 29 /PRNewswire/ -- Major health organizations, including the Centers for Disease Control and Prevention (CDC), recommend that NEW BRUNSWICK, N.J., April 16 /PRNewswire-FirstCall/ -- Johnson & Johnson will webcast its Annual Meeting of Shareholders at 10 a.m. (Eastern T Sales of EPS was What's happened in each state since the 1994 federal health reform debate is chronicled in a state-by-state analysis released during http://www.bioportfolio.com/news/More_Working_People_Go_Without_Health_Coverage_as.html - Tuesday March 24 2009 |
|
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
